1.
Community dynamics and the lower airway microbiota in stable chronic obstructive pulmonary disease, smokers and healthy non-smokers
by Einarsson, G G
Thorax, 2016-09, Vol.71 (9), p.795-803
2.
Pediatric severe asthma is characterized by eosinophilia and remodeling without T(H)2 cytokines
by Bossley, Cara J
Journal of allergy and clinical immunology, 2012-04, Vol.129 (4), p.974-82.e13
3.
Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
by Segal, Leopoldo N
Thorax, 2017-01, Vol.72 (1), p.13-22
4.
Characterization of microbiome in bronchoalveolar lavage fluid of patients with lung cancer comparing with benign mass like lesions
by Lee, Sang Hoon
Lung cancer (Amsterdam, Netherlands), 2016, Vol.102, p.89-95
5.
The lower airway microbiota in early cystic fibrosis lung disease: a longitudinal analysis
by Frayman, Katherine B
Thorax, 2017-12, Vol.72 (12), p.1104-1112
6.
Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients
by Alanio, A
Clinical microbiology and infection, 2011-10, Vol.17 (10), p.1531-1537
7.
Eosinophilic airway inflammation in asthmatic patients is associated with an altered airway microbiome
by Sverrild, Asger
Journal of allergy and clinical immunology, 2017-08, Vol.140 (2), p.407-417.e11
8.
Accuracy and impact of Xpert MTB/RIF for the diagnosis of smear-negative or sputum-scarce tuberculosis using bronchoalveolar lavage fluid
by Theron, Grant
Thorax, 2013-11, Vol.68 (11), p.1043-1051
9.
Corticosteroid therapy and airflow obstruction influence the bronchial microbiome, which is distinct from that of bronchoalveolar lavage in asthmatic airways
by Denner, Darcy R., PhD
Journal of allergy and clinical immunology, 2015, Vol.137 (5), p.1398-1405.e3
10.
Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid for the diagnosis of invasive aspergillosis in immunocompromised patients
by Bhimji, A
Clinical microbiology and infection, 2018-06, Vol.24 (6), p.640-645
11.
Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition
by Rogers, Geraint B
Thorax, 2013-08, Vol.68 (8), p.731-737
12.
The significance of distal bronchial samples with commensals in ventilator-associated pneumonia: Colonizer or pathogen?
by LAMBOTTE, Olivier
Chest, 2002, Vol.122 (4), p.1389-1399
13.
Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus az...
by Boch, T
Clinical microbiology and infection, 2016-10, Vol.22 (10), p.862-868
14.
Electronic nose analysis of exhaled breath to diagnose ventilator-associated pneumonia
by Schnabel, R.M
Respiratory medicine, 2015, Vol.109 (11), p.1454-1459
15.
Molecular quantification of bacteria from respiratory samples in patients with suspected ventilator-associated pneumonia
by Clavel, M
Clinical microbiology and infection, 2016-09, Vol.22 (9), p.812.e1-812.e7
16.
Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands
by van Ingen, J
Thorax, 2009-06, Vol.64 (6), p.502-506
17.
Microbial communities in the respiratory tract of patients with interstitial lung disease
by Garzoni, Christian
Thorax, 2013-12, Vol.68 (12), p.1150-1156
18.
Surveillance for lower airway pathogens in mechanically ventilated patients by metabolomic analysis of exhaled breath: a case-control study
by Fowler, Stephen J
Thorax, 2015-04, Vol.70 (4), p.320-325
19.
Aspergillus galactomannan detection in exhaled breath condensate compared to bronchoalveolar lavage fluid’ by Husain, et al
by Xu, C
Clinical microbiology and infection, 2018-09, Vol.24 (9), p.1021-1022
20.
Comparative analysis of the pulmonary microbiome in healthy and diseased pigs
by Li, Zongjie
Molecular genetics and genomics : MGG, 2020-09-17, Vol.296 (1), p.21-31
